Corporate Banner
Satellite Banner
Technology Networks Header
Monday, April 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Automated Immunosuppressive Drug Assays from Roche
Tuesday, June 25, 2013
Roche enables immunosuppressive drug assays to be consolidated onto main laboratory automated platforms.

Expert Potato Breeder Uses SDI’s Syngene G:BOX Image Analysis System
Monday, June 24, 2013
To help efficiently identify unknown varieties.

Tecan Cavro® Components Help in the Battle Against Infectious Diseases
Wednesday, June 19, 2013
NESDEP IU molecular diagnostic system designed to detect a wide range of pathogens.

bioMérieux’s New Formulation VITEK® 2 Fungal Susceptibility Card
Friday, June 14, 2013
Offers automated, standardized and rapid yeast susceptibility testing.

Agilent Launches RapidFire 365 High-Throughput Mass Spectrometry System
Tuesday, June 11, 2013
Product provides walkaway mass spectrometric analysis for researchers working on drug discovery, clinical research and forensic toxicology.

Holding the Right CARDs with Tecan Cavro® Components
Tuesday, June 11, 2013
Rheonix provides complete automation of sample processing and analysis using CARD® technology.

Fluxion Delivers First Commercial Shipments of IsoFlux™ System
Friday, June 07, 2013
Platform enables pharma, research, and diagnostic companies to utilize blood samples for cancer diagnostic breakthroughs.

GATC Biotech Offers World´s Fastest Exome Sequencing Service
Friday, June 07, 2013
InView™ 1-Week Exome Diagnostic for the detection of cancerous cells or other genetic diseases.

Roche Launches New Software Updates
Friday, June 07, 2013
New software tools for the LightCycler 96 and LightCycler Nano systems.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 405
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv